Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody

BACKGROUND: In this study, we describe the generation of a fully human monoclonal antibody (named ‘7NP2’) targeting human fibroblast activation protein (FAP), an antigen expressed in the microenvironment of different types of solid neoplasms. METHODS: 7NP2 was isolated from a synthetic antibody phag...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadal, Lisa, Peissert, Frederik, Elsayed, Abdullah, Weiss, Tobias, Look, Thomas, Weller, Michael, Piro, Geny, Carbone, Carmine, Tortora, Giampaolo, Matasci, Mattia, Favalli, Nicholas, Corbellari, Riccardo, Di Nitto, Cesare, Prodi, Eleonora, Libbra, Chiara, Galeazzi, Simone, Carotenuto, Claudiopietro, Halin, Cornelia, Puca, Emanuele, Neri, Dario, De Luca, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476130/
https://www.ncbi.nlm.nih.gov/pubmed/36104101
http://dx.doi.org/10.1136/jitc-2022-005282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476130/
https://www.ncbi.nlm.nih.gov/pubmed/36104101
http://dx.doi.org/10.1136/jitc-2022-005282

Ejemplares similares